Headquartered in Visakhapatnam, Biolibra Formulations manufactures, supplies and exports high-quality pharmaceutical formulations to domestic, UK and international markets — built on rigorous quality systems and a global mindset.
Biolibra Formulations Private Limited is a Visakhapatnam-headquartered pharmaceutical company built around three pillars — manufacturing excellence, regulatory rigour and a global trade-first outlook. From our base in Andhra Pradesh's Pharma City corridor, we develop, source and supply formulations that meet the standards demanded by modern healthcare systems, both at home and abroad.
We operate at the intersection of three opportunities: a fast-growing domestic Indian market, a transformative new India–UK trade corridor, and an expanding network of import-export partners across emerging and regulated markets. Our company structure is purpose-built for cross-border supply — combining the cost, scale and talent advantages of India with the quality discipline international buyers expect.
To make safe, affordable and high-quality medicine accessible — wherever it is needed.
To be a trusted Indian pharma partner across global markets, with a flagship presence in the UK trade corridor.
The India–UK Comprehensive Economic and Trade Agreement (signed July 2025) opens an unprecedented runway for Indian pharmaceutical exporters — with duty-free access on nearly 99% of tariff lines, mutual recognition of GMP standards, and reduced inspection duplication.
Biolibra Formulations is structured from day one to capitalise on this corridor — pairing UK-aligned quality systems with Indian manufacturing scale.
Discuss a UK supply partnershipFrom general medicines to specialty therapies, we offer a curated catalogue tailored to the needs of hospitals, retail chains, government tenders, and overseas distributors.
Antihypertensives, statins, antiplatelets and heart-failure therapies.
Broad-spectrum antibiotics, antifungals and antivirals across oral and injectable formats.
Oral antidiabetics, combination therapies and insulin-related formulations.
NSAIDs, analgesics, muscle relaxants and combination pain-management therapies.
PPIs, antacids, anti-emetics and digestive health formulations.
Vitamins, minerals, protein supplements and wellness formulations for retail and institutional channels.
We've designed Biolibra around three complementary verticals — each independently strong, together a moat.
A reliable supplier to hospitals, pharmacies, government tenders, and B2B distributors across India — backed by our Visakhapatnam fulfilment hub.
A purpose-built international trade vertical — leveraging Vizag's port advantage and the new India–UK FTA to move pharmaceutical product across borders, both ways.
We partner with brands, hospitals and overseas buyers to manufacture under their label — with shared QA oversight, bespoke packaging and full regulatory documentation.
International pharma trade isn't about shipping cartons — it's about regulatory alignment, cold-chain integrity, documentation discipline and partner trust. We've built each of those into the way we operate.
Every product line is vetted for the destination market's regulatory regime — MHRA, EMA, ANVISA, MOH, FDA and more.
Our Visakhapatnam base sits next to one of India's largest deep-water ports — direct ocean lanes to Europe, Africa, and South-East Asia.
Temperature-controlled handling, GDP-aligned logistics, full CoA / CoO / batch traceability for every shipment.
We don't chase spot deals — we build long-cycle distributor relationships with predictable supply and pricing.
Partner facilities operating to WHO-GMP equivalent standards.
CoA, CoO, MSDS, BMR, stability data — provided per shipment.
CTD/eCTD-ready dossiers for MHRA, EMA, ANVISA and others.
Batch-level traceability, serialisation-ready packaging.
Whether you're a UK distributor exploring new sourcing partnerships, a hospital procurement lead, or a brand looking for a contract manufacturing partner — we'd love to hear from you.